Evoke Pharma Inc. (EVOK)
2.79
0.00 (0.00%)
At close: Mar 28, 2025, 3:49 PM
2.78
-0.36%
After-hours: Mar 28, 2025, 05:11 PM EDT
Evoke Pharma Balance Sheet Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 13.6M | 4.74M | 9.84M | 9.14M | 8.07M | 5.66M | 5.32M | 7.68M | 9.01M | 8.69M | 14.16M | 24.2M | 116.01K | 865.88K |
| Short-Term Investments | 13,596.6B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 126.93B | 241.64K | -129.07K | -12.43K | 11.55K | 11.55K | 11.55K | 11.55K | 11.55K | 8K | 53.02K | 555.5K | n/a | n/a |
| Receivables | 2,420.4B | 673.07K | 624.83K | 295.19K | 23.31K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | 445.08B | 481.84K | 289.38K | 185.53K | 236.48K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 775.84B | 932.57K | 964.5K | 935.3K | 952.06K | 581.71K | 329.22K | 251.05K | 275.71K | 833.28K | 1.09M | 234.26K | n/a | 39.46K |
| Total Current Assets | 17,237.9B | 6.83M | 11.72M | 10.56M | 9.28M | 6.25M | 5.65M | 7.93M | 9.28M | 9.52M | 15.25M | 24.43M | 116.01K | 905.34K |
| Property-Plant & Equipment | 154.18B | n/a | 129.07K | 12.43K | 141.71K | 138.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 281.11B | 241.64K | 129.07K | 12.43K | 153.26K | 150.09K | 11.55K | 11.55K | 11.55K | 8K | 53.02K | 555.5K | n/a | n/a |
| Total Assets | 17,519B | 7.07M | 11.85M | 10.57M | 9.43M | 6.4M | 5.66M | 7.94M | 9.29M | 9.53M | 15.3M | 24.99M | 116.01K | 905.34K |
| Account Payables | 2.34M | 1.71M | 868.31K | 874.03K | 1.27M | 1.03M | 476.2K | 1.05M | 478.22K | 927.61K | 989.63K | 284.92K | 96.8K | n/a |
| Deferred Revenue | n/a | n/a | n/a | n/a | n/a | -1.03M | n/a | n/a | n/a | -927.61K | -989.63K | -284.92K | n/a | n/a |
| Short-Term Debt | 5.06M | 5M | 258.15K | 24.86K | 245.87K | 277.08K | n/a | n/a | n/a | 146.05K | 150.43K | 1.44M | n/a | n/a |
| Other Current Liabilities | 10,380B | 2.94M | 528.08K | 506.89K | 6.02M | 704.62K | 1.16M | 1.03M | 933.45K | 760.78K | 731.56K | 557.4K | 473.61K | 334.5K |
| Total Current Liabilities | 10,380B | 9.65M | 1.65M | 1.41M | 7.54M | 2.02M | 1.63M | 2.07M | 1.41M | 1.83M | 1.87M | 2.28M | 570.41K | 334.5K |
| Long-Term Debt | 100.96K | 5M | 5M | 5M | 5M | n/a | n/a | n/a | n/a | 4.23M | 4.24M | 1.51M | 979.79K | n/a |
| Other Long-Term Liabilities | n/a | 1.61M | 1.11M | 612.29K | 112.99K | n/a | n/a | 3.7M | 4.1M | n/a | n/a | 6.83K | 18.23M | n/a |
| Total Long-Term Liabilities | 100.96K | 6.61M | 6.11M | 5.61M | 5.11M | n/a | n/a | 3.7M | 4.1M | 4.23M | 4.24M | 1.52M | 19.2M | 18.23M |
| Total Liabilities | 10,481B | 9.65M | 7.77M | 7.02M | 12.65M | 2.02M | 1.63M | 5.78M | 5.51M | 6.07M | 6.11M | 3.8M | 19.78M | 18.56M |
| Total Debt | 5.16M | 5M | 5.13M | 5.01M | 5.25M | 138.54K | n/a | n/a | n/a | 4.38M | 4.39M | 2.95M | 979.79K | n/a |
| Common Stock | 149.00 | 334.00 | 334.00 | 3.27K | 2.66K | 2.44K | 1.74K | 1.54K | 1.24K | 720.00 | 611.00 | 610.00 | 124.00 | 124.00 |
| Retained Earnings | -128,791.6B | -123.44M | -115.65M | -107.42M | -98.89M | -85.73M | -78.6M | -71.04M | -58.81M | -48.06M | -35.94M | -22.69M | -19.86M | -17.84M |
| Comprehensive Income | n/a | n/a | n/a | n/a | -0.00 | n/a | 0.00 | 0.00 | n/a | -0.00 | n/a | -24.99M | -18.23M | n/a |
| Shareholders Equity | 7,038B | -2.58M | 4.08M | 3.56M | -3.21M | 4.38M | 4.03M | 2.17M | 3.79M | 3.46M | 9.19M | 21.18M | -19.66M | -17.65M |
| Total Investments | 13,596.6B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |